HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ernst J Schaefer Selected Research

Gemfibrozil (Lopid)

1/2008Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
7/2006The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).
3/2006Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
5/2003Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
3/2003HDL in atherosclerosis: actor or bystander?
12/2002Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ernst J Schaefer Research Topics

Disease

65Coronary Disease (Coronary Heart Disease)
01/2022 - 02/2002
36Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2002
13Heart Diseases (Heart Disease)
03/2022 - 02/2002
13Insulin Resistance
10/2019 - 12/2002
13Coronary Artery Disease (Coronary Atherosclerosis)
03/2018 - 04/2003
12Atherosclerosis
04/2016 - 03/2002
10Dyslipidemias (Dyslipidemia)
10/2019 - 06/2002
10Hypertriglyceridemia
01/2019 - 05/2002
9Obesity
03/2019 - 06/2002
9Inflammation (Inflammations)
10/2017 - 01/2011
7Xanthomatosis (Xanthoma)
07/2021 - 02/2008
7Myocardial Infarction
01/2019 - 05/2003
7Stroke (Strokes)
01/2019 - 03/2003
6Hypertension (High Blood Pressure)
01/2021 - 02/2002
6Overweight
03/2019 - 11/2005
6Hypercholesterolemia
10/2018 - 03/2002
6Type 2 Diabetes Mellitus (MODY)
10/2017 - 06/2003
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 10/2003
5Diabetes Mellitus
01/2021 - 12/2002
5Hyperlipidemias (Hyperlipidemia)
03/2018 - 09/2008
5Tangier Disease
09/2016 - 04/2003
5Weight Loss (Weight Reduction)
11/2015 - 04/2003
4Body Weight (Weight, Body)
11/2015 - 10/2002
3Anemia
07/2021 - 11/2011
3Pancreatitis
01/2019 - 05/2002
3Renal Insufficiency (Renal Failure)
01/2019 - 11/2011
3Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
09/2016 - 11/2011
3Dementia (Dementias)
05/2012 - 01/2006
3Retinitis Pigmentosa (Pigmentary Retinopathy)
04/2010 - 09/2004
2Cataract (Cataracts)
07/2021 - 09/2018
2Splenomegaly
07/2021 - 03/2014
2Cerebrotendinous Xanthomatosis
07/2021 - 09/2018
2Sitosterolemia
07/2021 - 01/2018
2Prediabetic State (Prediabetes)
10/2019 - 10/2017
2Thyroid Diseases (Thyroid Disease)
01/2019 - 10/2018
2Arcus Senilis
08/2014 - 02/2008
2Corneal Opacity
03/2014 - 11/2009
2Osteoporosis
05/2012 - 05/2011

Drug/Important Bio-Agent (IBA)

39HDL CholesterolIBA
01/2021 - 02/2002
32LipidsIBA
01/2019 - 07/2002
30CholesterolIBA
01/2022 - 02/2002
29LDL CholesterolIBA
01/2021 - 02/2002
28Lipoproteins (Lipoprotein)IBA
01/2021 - 02/2002
25HDL LipoproteinsIBA
01/2018 - 10/2002
21oxidized low density lipoproteinIBA
01/2021 - 10/2003
20Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2018 - 10/2002
18LDL Lipoproteins (beta Lipoproteins)IBA
01/2021 - 10/2002
18Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2017 - 06/2002
15Triglycerides (Triacylglycerol)IBA
01/2021 - 12/2002
15ApolipoproteinsIBA
07/2019 - 10/2002
13Glucose (Dextrose)FDA LinkGeneric
10/2019 - 05/2002
12Atorvastatin (Lipitor)FDA Link
11/2012 - 10/2002
10Insulin (Novolin)FDA Link
10/2019 - 06/2002
9C-Reactive ProteinIBA
01/2019 - 01/2005
9Pravastatin (Pravachol)FDA LinkGeneric
07/2014 - 10/2002
8Apolipoproteins E (ApoE)IBA
01/2019 - 12/2003
7Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2008
7Docosahexaenoic AcidsIBA
11/2016 - 09/2004
6Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2016 - 09/2004
6AlbuminsIBA
01/2016 - 08/2009
6Simvastatin (Zocor)FDA LinkGeneric
03/2014 - 10/2002
6Gemfibrozil (Lopid)FDA LinkGeneric
01/2008 - 12/2002
5Apolipoproteins B (ApoB)IBA
07/2019 - 06/2002
5Cholesterol Esters (Cholesteryl Esters)IBA
09/2016 - 08/2006
5Apolipoprotein B-100 (Apo B 100)IBA
04/2016 - 10/2004
5Apolipoproteins AIBA
04/2016 - 03/2004
5Niacin (Nicotinic Acid)FDA LinkGeneric
12/2013 - 04/2003
5Cholesterol Ester Transfer ProteinsIBA
06/2013 - 07/2002
4Fatty Acids (Saturated Fatty Acids)IBA
03/2022 - 09/2004
4Adenosine Triphosphate (ATP)IBA
01/2022 - 08/2008
4Lipoprotein(a)IBA
01/2021 - 06/2011
4AdiponectinIBA
10/2020 - 08/2011
4Biomarkers (Surrogate Marker)IBA
09/2013 - 12/2006
4torcetrapibIBA
06/2013 - 05/2005
4Lovastatin (Mevacor)FDA LinkGeneric
09/2008 - 10/2002
4Fibric Acids (Fibrates)IBA
01/2008 - 05/2002
3Scavenger Receptors (Scavenger Receptor)IBA
01/2022 - 06/2003
3gamma-sitosterol (beta-sitosterol)IBA
07/2021 - 04/2003
3lipoprotein cholesterolIBA
01/2021 - 07/2009
3salicylsalicylic acid (salsalate)IBA
10/2017 - 11/2015
3Rosuvastatin Calcium (Crestor)FDA Link
01/2017 - 02/2011
3Fish OilsIBA
11/2016 - 03/2008
3CarbohydratesIBA
11/2015 - 11/2005
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
09/2015 - 09/2013
3Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA
06/2014 - 08/2008
3FructoseIBA
12/2013 - 05/2009
3Estrogens (Estrogen)FDA Link
01/2011 - 06/2002
3Vitamin A (Retinol)FDA LinkGeneric
04/2010 - 09/2004
3Apolipoprotein A-II (Apolipoprotein A2)IBA
09/2008 - 03/2004
3FluvastatinFDA Link
05/2005 - 10/2002
2Cholestanol (Coprostanol)IBA
07/2021 - 09/2018
2Apolipoprotein C-II (ApoC2)IBA
01/2019 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
10/2018 - 09/2015
2Eicosapentaenoic AcidIBA
11/2016 - 08/2015
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
10/2016 - 10/2004
2Fenofibrate (CiL)FDA LinkGeneric
04/2016 - 11/2012
2LDL Receptors (LDL Receptor)IBA
03/2014 - 09/2008
2Leucine (L-Leucine)FDA Link
03/2013 - 10/2004

Therapy/Procedure

19Therapeutics
10/2018 - 05/2002
3Secondary Prevention
12/2005 - 07/2005